In the news release, Medeon Biodesign Announces Investing in
Panther Orthorpedic for Orthopedic Extremity Applications, issued
28-Mar-2017 by Medeon Biodesign, Inc.
over PR Newswire, we are advised by the company that its name in
the headline should be "Panther Orthopedics" rather than "Panther
Orthorpedic" as originally issued inadvertently. The complete,
corrected release follows:
Medeon Biodesign Announces Investing in Panther Orthopedics for
Orthopedic Extremity Applications
TAIPEI, Taiwan, March 28, 2017 /PRNewswire/ -- Medeon
Biodesign, Inc., a Taiwan medical
device company, is pleased to announce that the Company led and
successfully closed the Series A investment of Panther Orthopedics,
Inc., a San Jose, CA start-up
pioneering innovative dynamic fixation solutions for orthopedic
extremity applications.
The orthopedic extremity device market continues to expand
rapidly, primarily due to procedure volume growth, lifestyle
influences and favorable demographics. Nevertheless, the market
need for better fixation products for both trauma and sports
medicine in fracture fixation and joint stabilization applications
is still under served. "Current options for fixation include
cortical screw and suture button flexible fixation devices.
However, many limitations associated with currently marketed
products are not being addressed," said Dr. Kathryn Stecco, CEO and co-founder of Panther
Orthopedics. "We have developed an innovative platform for dynamic
extremity fixation, which we believe will provide continuous
compression during the healing period while still allowing
micromotion. The intuitive design of our solutions is easy to use
and intended to eliminate the need for most second surgery removal,
providing significant benefits for both the patients and the entire
healthcare system."
"We are excited to lead the investment of Panther Orthopedics to
address the long-standing need of better clinical fixation during
the healing period for orthopedic extremity applications," said Dr.
Yue-Teh Jang, CEO of Medeon
Biodesign. "We are impressed with the team's extensive experience,
profound knowledge of orthopedic applications and broad KOL
networking. We are confident that the Panther Orthopedics' unique
and innovative dynamic fixation solutions will be very welcome by
the clinical community in the near future."
About Medeon Biodesign
Medeon Biodesign (TPEx: 6499) is a publicly traded company
located in Taipei, Taiwan, and
currently listed on Taipei Exchange. The company focuses on the
development of medical devices for minimally invasive surgeries to
treat diseases of sizable patient population, such as
cardiovascular, peripheral vascular, orthopedic, neurosurgery,
obesity, gastroenterology, hematology, nephrology, gynecology,
urology, and plastic surgery. For more information, please visit
www.medeonbio.com/en.
Contacts
Dr. Yi-Ju
Chen
+886.2.2881.6686
ir@medeonbio.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/medeon-biodesign-announces-investing-in-panther-orthorpedic-for-orthopedic-extremity-applications-300430173.html
SOURCE Medeon Biodesign, Inc.